Last reviewed · How we verify

NCT03043495

Dexamethasone Dose in Low Volume Bupivacaine USG Supraclavicular Block

Status unknown Phase 4 Last updated 6 February 2017
What this trial tests

Phase 4 trial testing Ultrasound guided supraclavicular brachial plexus block in Dexamethasone in 40 participants. Status unknown.

Timeline
1 October 2016
Primary endpoint
1 April 2018
1 June 2018

Quick facts

Lead sponsorEslam Ayman Mohamed Shawki
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment40
Start date1 October 2016
Primary completion1 April 2018
Estimated completion1 June 2018
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Eslam Ayman Mohamed Shawki — full company profile →

Who can join

Adults 18 to 80, any sex, with Dexamethasone or Supraclavicular Brachial Plexus Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A dose-ranging study to test various doses of Dexamethasone (2, 4 \& 8 mg) to be used as an adjuvant to Local anesthetic drugs in ultrasound guided low volume Supraclavicular brachial plexus block to find the best balance between valuable effects (mainly duration of analgesic Effect) and side-effects (mainly increased random blood sugar levels)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Dexamethasone

Currently open trials in the same condition.

Other Eslam Ayman Mohamed Shawki trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03043495.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing